光正眼科涨2.02%，成交额3562.38万元，主力资金净流入59.56万元

Core Viewpoint - Guangzheng Ophthalmology's stock price has shown a year-to-date increase of 24.73%, indicating positive market sentiment despite a recent decline in revenue [2] Financial Performance - As of September 30, 2025, Guangzheng Ophthalmology reported a revenue of 663 million yuan, a year-on-year decrease of 5.05%, while net profit attributable to shareholders was 173,400 yuan, reflecting a significant year-on-year growth of 100.83% [2] - The company has cumulatively distributed 14.75 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [3] Stock Market Activity - On October 31, Guangzheng Ophthalmology's stock rose by 2.02%, reaching 4.54 yuan per share, with a trading volume of 35.62 million yuan and a turnover rate of 1.55% [1] - The net inflow of main funds was 595,600 yuan, with large orders accounting for 14.03% of purchases and 12.36% of sales [1] Shareholder Structure - As of September 30, 2025, the number of shareholders decreased by 11.99% to 38,700, while the average circulating shares per person increased by 14.07% to 13,186 shares [2] - Notable changes in institutional holdings include an increase in shares held by Noan Multi-Strategy Mixed A and the entry of Jinyuan Shun'an Yuanqi Flexible Allocation Mixed as a new major shareholder [3]